Opioid Pain Contracts: A Resident Driven Quality Improvement Project

Similar documents
1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I

Prescription Drug Abuse: Colorado and Nationwide

Dr. Smith. Roneet Lev, MD FACEP Chief, Emergency Department Scripps Mercy Hospital Chair, San Diego Prescription Drug Abuse Medical Task Force

PROGRAM FOR THE USE OF CONTROLLED SUBSTANCES OR PRECURSOR/LIST CHEMICALS IN RESEARCH

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Drug Trends &Trafficking I/S Brian Dempsey

Technician Tutorial: Scheduled Drugs

20/0.8mg, 30/1.2mg, Films 90 MME/day Belbuca (buprenorphine) 75mcg, 150mcg, 300mcg, 450mcg 60 units per 90 days

Urine Opioid Dependency Panel (UODP) 1

REB CLOSE, MD Community Hospital of the Monterey Peninsula

Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM. Preventative Education: Substance Use Disorder

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Aetna s Initiative on the Opioid Epidemic

Session II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

[ ASSESSING THE BURDEN OF ILLICIT DRUGS AND ALCOHOL ABUSE:] Macomb County Office of Substance Abuse. A Focus on Heroin and Prescription Drug Abuse

NIDA Quick Screen V1.0F1

Controlled Substances in the Lab Environment STACI MEADE JAMES PITCHER

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Practical Pain Management Leah Centanni, MSN, FNP-C, Asst. Clinical Professor CANP Conference March 22, 2014

Pharmacy Medical Necessity Guidelines: Opioid Analgesics

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

The Latest Prescription Trends for Controlled Prescription Drugs

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.

Many companies conduct drug screenings. But you better avoid the following nine items and save yourself a world of frustration, if you need

ARKANSAS DEPARTMENT OF HEALTH

Policy and Issuance Patient Age Group: ( ) N/A ( ) All Ages ( ) Newborns ( X) Pediatric ( X) Adult

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Lesson 5 - Regulations and Standards Assignment Answer Key

Buprenorphine & Controlled Substance Treatment Agreement

Preventing Prescription Drug and Heroin Abuse and Deaths: Practical Strategies. July 12, 2015

Changing Prescribing Practices In Dentistry

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

Countable Controlled Substances What are they and why do we need to count them so carefully every day?

LORAIN COUNTY COMMISSIONERS

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Preventing Medication Diversion

Risk Reduction Strategies in Pain Management

Neurobiology of Drug Abuse and Addiction PSYC 450

Prescription Drug Abuse

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Prescription Drug Impact in the Workplace

Substance Use and Misuse in the Military

Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Opioid Analgesics. Recommended starting dose for opioid-naïve patients

Opiate Use among Ohio Medicaid Recipients

Clinical Safety & Effectiveness Cohort # 11

Prescription Drug Dispensing in Oregon

Regulatory Issues and Opioids. Ileana Leyva, MD FAAHPM Erin Bagwell, LCSW Sean O Mahony, MB BCH BAO, MS

Subject: Pain Management (Page 1 of 7)

ADMISSION INTRACTABLE PAIN PROGRAM

Preventing Medication Diversion

Medication Assisted Treatment

Prescription Drug Monitoring Reference Guide: 2017

Drug Adherence Assessment Report

Behavioral Health in PACE: Substance Abuse

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015

CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY?

The Caring Center of Wichita LLC. General Information Client Name:

NIDA-Modified ASSIST Prescreen V1.0 1

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

Recognizing Narcotic Abuse and Addiction and Helping Those With It

Tracker e-prescribing 101. The Complete Guide

PAIN CONTROL IN THE AGE OF ADDICTION

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Preventing Opioid Misuse and Use: The Lucky Preventionist s Guide to Strategic Planning

The Unseen Consequences of Prescription Drug Abuse. Stephen Loyd, M.D.

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016


Top 10 narcotic pain pills

Morphine er to oxycontin conversion

2/21/2018. What are Opioids?

Prescription Safety What you need to know when you take a prescription home

PATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone

Dr Alistair Dunn. Lead Clinician Northland Health Community Mental Health & Addictions Northland DHB Whangarei

DAWN. In 2009, nearly 4.6 million emergency

In 2009, nearly 4.6 million emergency

Responding to the Opioid Addiction Epidemic

Federal Trafficking Penalties (As of January 1, 1996)

Pain Medication Management Program Supports Patient Outcomes and Adherence

Generic Label Name Drug Strength Dosage Form Example Product (s) MME/Unit ACETAMINOPHEN WITH CODEINE

Opioid Prescription and Illicit Drug Overdoses: On the Rise

Opioid Prescribing Guidelines for Patients in the Emergency Department

Federal Response. Rx Abuse & Diversion Current Trends. Pharmaceutical Drug Diversion 3/31/2017

Montgomery County Poisoning Death Review

Michael M. Miller, MD, FASAM, FAPA

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine

National 800 Phone Number. What is Misuse? Iowa s PCC. Commonly Misused Rx Drugs. Pharmageddon: The Rx Drug Abuse Crisis 04/07/14 1

WORRIED ABOUT PAIN AFTER ORAL SURGERY?

Transcription:

Opioid Pain Contracts: A Resident Driven Quality Improvement Project A Response to the Opioid Epidemic Dr. Phillip Knouse Dr. Victoria Montgomery

Disclosure None

Objectives Discuss the current Opioid Epidemic Understand the value of pain contracts for the primary care physician Recognize available resources for opioid prescribing habits and managing substance abuse patients

The Opioid Epidemic Opioid-related deaths have more than quadrupled since 2000 More than 2 million people in the US are addicted to prescription opioids More than 12 million report having misused the prescription opioids in 2015 Prescription opioid addiction and misuse are contributing to a resurgence in heroin use and the spread of HIV and hepatitis C

National Center for health Statistics 2017

Drug Overdose Death Rate

Number and age-adjusted rates of drug overdose deaths by state, US 2016

The Roots of the Epidemic

Risk Factors for Prescription Opioid Abuse and Overdose

How is the Opioid Epidemic being targeted?

Illinois Prescription Monitoring Program

Controlled Substance Schedules Schedule I Not currently accepted for medical use, very high potential for abuse Ex: Heroin, LSD, Ecstasy Schedule II / II N High potential for abuse that can lead for severe psychological/physical dependence Ex: Next slide Schedule III / III N Less potential for abuse, moderate/low physical dependence Tylenol w/ codeine, buprenorphine (suboxone), Marinol, Ketamine, anabolic steriods Schedule IV Low potential for abuse relative to substances in Schedule III Xanax, Soma, Clonazepam (Klonopin), diazepam (Valium), Lorazpam (Ativan), zolpidem (Ambiem) Schedule V Low potential for abuse and consists mainly of limited quantities of certain narcotics Ex: Robitussin AC, Phenergan w/ Codeine, Cough syrup with codiene

Schedule II / II N (2/2N) High potential for abuse that can lead to severe dependence Schedule II narcotics Hydromorphone (Dilaudid) Methadone Merperidine (Demerol) Oxycodone (Oxycontin/Percocet) Schedule II N stimulants Amphetamine (Dexedrine/Adderall) Methamphetamine (Desoxyn) Methylphenidate (Ritalin) Lisdexamfetamine (Vyvanse) Fentanyl (Sublimaze/Duragesic) Morphine Opium Codeine Hydrocodone Hydrocodone/acetaminophen Tapentadol (nucynta) OxyMorphone (Opana)

Rx Schedule II: not for more than 30 day supply Valid for 90 days after date of issuance No refills Schedule III-V: Up to 5 refills Filled or refilled more than 6 months after day of issuance

Aetna s Super Prescriber Program

OptumRx s Opioid Risk Management Program

Association of American Medical Colleges

Lutheran General Hospital Internal Medicine Residency Opioid Task Force Team: Dr. Jill Patton Dr. John Berry Dr. Gaursh Soni Dr. Ahmed Khattab Dr. Philip Knouse Dr. Victoria Montogmery

Our Project AIM: To increase the use of pain contracts at Nesset Out Patient Internal Medicine by 20% over 6 months in an attempt to In an attempt to: Decrease the volume of opioids prescribed Decrease the length of time patients use opioids Increase adherence to a single provider Reduce risk for opioid addiction and abuse

Our Project Nesset Outpatient center has 2918 (26%) of the patients on schedule 2 narcotics Patients that had been on opioids over a 6 week period were asked to sign a pain contract The project launched on March 1, 2018 and the use of pain contracts will be reassessed on September, 1 2018 (6 months)

Training Provided an 1 hour educational lecture to residents Opioid Epidemic Opioid contracts How to use them, when to use them, how to find them Displayed a 15 minute demonstration video How to approach patients about their drug use How to discuss with patient about pain contracts Provided education to outpatient supportive staff about the project and monitoring Sent multiple reminder emails about the project

Results Increased from 0 contracts to 5 contracts

Barriers Time Issue with time to discuss pain contracts Lack of patient follow up if asked to come back to discuss a pain contract Difficulty of EMR to find location of prior Opioid Contracts Residents did not feel comfort discussing opioid contracts Lack of patient participation Stigma against pain contracts

Outcomes Physicians are not comfortable with the idea of addressing pain contract Agreement protects patient s access to medication and protects the clinician s license to prescribe them Solution: More training for physicians Will extend the study to December 1 st 2018

Pain Contracts

What is a Pain Contract? A documentation of understanding between a doctor and patient. Entails: What medications the agreement includes What risks/benefits of medication Procedures of emergency care Non-adherence

Overview of a Pain Contract 1 provider is giving narcotics Take as prescribed Taking responsibility for refills No additional refills No early refill requests 1 pharmacy Scheduled appointments will be kept No other illicit drugs use Drug screens Terminations clause

Patient s rights Have pain prevented or controlled adequately. Have pain and medication history taken. Have pain questions answered. Know what medication, treatment or anesthesia will be given. Know the risks, benefits, and side effects of treatment. Ask for changes in treatments if pain persists. Receive compassionate and sympathetic care.

Example of Pain Contract

Discussing the Agreement Plan

Before Discussing the Agreement Build the relationship and establish rapport Assess the 6 A s of Opioid Therapy Monitoring 1. Activity 2. Analgesia 3. Affect 4. Adjuncts 5. Adverse effects 6. Aberrant behavior to their drug use

General Guidelines for a Successful Agreement Plan Neutral non-confrontational language A comprehensive pain management plan Emphasize the clinician s responsibility and the agreement protects the patient s access to scheduled medications and protects the clinician s license to prescribe them Describe actions the clinician may take

https://www.youtube.com/watch?v=so7rgnumqqq&feature=youtu.be

CME credit available